VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents – Benzinga
|
VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents
Benzinga VetStem Biopharma, Inc., announced the purchase of 24 issued US and foreign patents in the field of adipose stem cell therapy. These already issued patents cover a wide range of methods and uses of adipose stem cells including coverage for therapeutic … |
